0,952  0,001  Cholesterol antagonist
0,952  0,003  Respiratory analeptic
0,950  0,002  Antihypercholesterolemic
0,940  0,003  Teratogen
0,937  0,003  Embryotoxic
0,933  0,001  UGT1A4 substrate
0,933  0,002  Chemopreventive
0,916  0,004  Carcinogenic
0,907  0,004  TNF expression inhibitor
0,902  0,003  CYP2C19 substrate
0,894  0,003  NOS3 expression inhibitor
0,888  0,004  Chemoprotective
0,865  0,002  UGT2B1 substrate
0,856  0,004  Analeptic
0,851  0,007  CYP3A4 substrate
0,851  0,011  Apoptosis agonist
0,844  0,010  Antiinflammatory
0,831  0,003  Sulfotransferase substrate
0,830  0,003  Proliferative diseases treatment
0,831  0,007  Caspase 9 stimulant
0,798  0,002  Hair growth stimulant
0,797  0,005  Bone diseases treatment
0,796  0,005  Sensitization
0,785  0,001  UGT2B7 substrate
0,778  0,001  Cholesterol synthesis inhibitor
0,790  0,013  Transcription factor NF kappa B inhibitor
0,775  0,003  Anesthetic
0,760  0,005  Atherosclerosis treatment
0,755  0,003  Anesthetic general
0,753  0,001  UGT2B4 substrate
0,756  0,005  Antiosteoporotic
0,740  0,005  Hepatic disorders treatment
0,738  0,004  UGT1A1 substrate
0,723  0,011  CYP2C9 substrate
0,708  0,004  UDP-glucuronosyltransferase substrate
0,721  0,018  Antineoplastic (breast cancer)
0,702  0,005  Lipoprotein disorders treatment
0,697  0,002  Pregnane X receptor agonist
0,698  0,006  NOS2 expression inhibitor
0,685  0,004  Antipruritic, allergic
0,684  0,008  CTGF expression inhibitor
0,679  0,004  Prostatic (benign) hyperplasia treatment
0,671  0,003  Androgen antagonist
0,654  0,002  Antihyperlipoproteinemic
0,657  0,006  UGT1A6 substrate
0,652  0,008  Antioxidant
0,642  0,001  5-Alpha-reductase inhibitor
0,651  0,013  Prostate cancer treatment
0,642  0,009  Cytotoxic
0,635  0,005  Amyotrophic lateral sclerosis treatment
0,615  0,011  Immunosuppressant
0,612  0,009  Antipsoriatic
0,606  0,009  Apoptosis antagonist
0,593  0,004  UGT1A3 substrate
0,591  0,003  Anticataract
0,590  0,002  Abortion inducer
0,577  0,003  Interferon gamma antagonist
0,589  0,017  Antineoplastic (ovarian cancer)
0,571  0,003  Autism spectrum disorders treatment
0,564  0,002  UGT2B9 substrate
0,561  0,002  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,557  0,002  Sodium/bile acid cotransporter inhibitor
0,555  0,004  Antiacne
0,570  0,020  Immunostimulant
0,561  0,015  Antineoplastic (pancreatic cancer)
0,562  0,017  Antineoplastic (melanoma)
0,553  0,012  Nitric oxide antagonist
0,545  0,005  Phospholipase C inhibitor
0,543  0,009  Hypolipemic
0,561  0,031  Alzheimer's disease treatment
0,535  0,006  Skin whitener
0,528  0,004  Prostate disorders treatment
0,536  0,016  Antifungal
0,532  0,014  Metabolic disease treatment
0,554  0,037  Cyclophilin D inhibitor
0,554  0,037  Antidiabetic
0,521  0,008  Antineoplastic (liver cancer)
0,518  0,005  Contraceptive
0,506  0,004  Antiinfertility, female
0,506  0,007  Interleukin 2 agonist
0,516  0,019  AR expression inhibitor
0,496  0,001  5-Alpha-reductase 1 inhibitor
0,491  0,003  Antipruritic, non-allergic
0,493  0,007  Antiviral (Herpes)
0,483  0,004  Lipocortins synthesis antagonist
0,481  0,004  Retinoprotector
0,486  0,011  Myocardial infarction treatment
0,483  0,008  Diuretic
0,511  0,038  Antileukemic
0,472  0,001  5-Alpha-reductase 2 inhibitor
0,478  0,008  Melanin inhibitor
0,490  0,025  Immunomodulator
0,472  0,008  Hepatoprotectant
0,462  0,004  Hedgehog signaling inhibitor
0,454  0,005  DNA polymerase I inhibitor
0,471  0,025  Antiepileptic
0,459  0,013  Sedative
0,462  0,027  Radioprotector
0,434  0,004  Contraceptive female
0,435  0,008  Amylase inhibitor
0,474  0,048  Antibacterial
0,458  0,032  CYP2D6 substrate
0,434  0,010  Carcinogenic, group 3
0,415  0,002  Androgen agonist
0,449  0,036  Inflammatory Bowel disease treatment
0,436  0,026  Mutagenic
0,405  0,002  Liver X receptor alpha agonist
0,442  0,045  Antineoplastic (colorectal cancer)
0,439  0,043  Stroke treatment
0,392  0,001  Glycine receptor agonist
0,394  0,004  Farnesoid X receptor antagonist
0,429  0,044  Antineoplastic (colon cancer)
0,379  0,002  Bile acid receptor antagonist
0,408  0,032  Cytostatic
0,387  0,021  Interleukin agonist
0,401  0,036  Antineoplastic (glioma)
0,373  0,009  Antiviral (Influenza A)
0,370  0,007  Psychosexual dysfunction treatment
0,402  0,039  ICAM1 expression inhibitor
0,369  0,010  Protein kinase stimulant
0,361  0,004  ABCA1 expression enhancer
0,360  0,004  Choleretic
0,417  0,061  Antineoplastic (lung cancer)
0,357  0,003  Actinic keratosis treatment
0,389  0,038  Antineoplastic (cervical cancer)
0,369  0,019  Skin irritative effect
0,351  0,005  LDLR expression enhancer
0,360  0,016  Antiviral (Influenza)
0,387  0,048  Caspase 3 stimulant
0,373  0,036  Antiprotozoal (Leishmania)
0,348  0,012  UGT2B15 substrate
0,367  0,031  Antineoplastic (renal cancer)
0,343  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,336  0,004  Alcohol dehydrogenase substrate
0,338  0,007  Antifungal enhancer
0,357  0,028  Antiulcerative
0,332  0,003  CDC25A inhibitor
0,411  0,088  Antiarthritic
0,350  0,032  Angiogenesis stimulant
0,348  0,034  Antineoplastic (endocrine cancer)
0,337  0,025  Muscle relaxant
0,318  0,007  Liver cirrhosis treatment
0,313  0,004  UGT2B10 substrate
0,355  0,050  Antineoplastic (brain cancer)
0,342  0,037  Antineoplastic (glioblastoma multiforme)
0,318  0,016  Protein-tyrosine phosphatase inhibitor
0,323  0,026  Eye irritation, high
0,336  0,042  Free radical scavenger
0,341  0,048  Hypoxia-inducible factor 1 alpha inhibitor
0,291  0,002  Arachidonic acid antagonist
0,322  0,045  Antineoplastic (lymphoma)
0,326  0,051  Antineoplastic (multiple myeloma)
0,280  0,005  Estrogen agonist
0,358  0,084  Antiobesity
0,320  0,050  Antipyretic
0,320  0,054  UGT1A9 substrate
0,267  0,002  RNA-directed RNA polymerase stimulant
0,315  0,051  DNA damaging
0,281  0,021  NOS3 expression enhancer
0,284  0,027  Diabetic retinopathy treatment
0,287  0,038  Wound healing agent
0,303  0,056  Renal disease treatment
0,253  0,008  Contraceptive male
0,282  0,039  Platelet adhesion inhibitor
0,240  0,002  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,240  0,003  Glycine receptor antagonist
0,259  0,024  Liver fibrosis treatment
0,236  0,004  Estrogen receptor alpha agonist
0,259  0,028  Growth factor agonist
0,232  0,003  Anticholelithogenic
0,287  0,059  Tumour necrosis factor alpha release inhibitor
0,230  0,002  Anabolic
0,283  0,057  Cardiodepressant
0,260  0,033  Neurotrophic factor enhancer
0,230  0,006  Postmenopausal disorders treatment
0,237  0,014  Endometrios treatment
0,229  0,007  Aromatase inhibitor
0,267  0,047  Antiparkinsonian, rigidity relieving
0,235  0,015  Neurotrophic factor
0,274  0,054  Gastrin inhibitor
0,222  0,004  Hypercalcemia treatment
0,323  0,108  CYP2C19 inhibitor
0,213  0,003  UGT2B11 substrate
0,234  0,024  Antidiabetic (type 1)
0,224  0,015  Microtubule formation inhibitor
0,259  0,052  Antihypertriglyceridemic
0,283  0,076  5 Hydroxytryptamine release stimulant
0,247  0,047  Antialcoholic
0,255  0,058  Antiparasitic
0,199  0,004  Hyperparathyroidism treatment
0,196  0,002  Na+ K+ transporting ATPase inhibitor
0,275  0,081  CYP1A2 substrate
0,194  0,005  Lanosterol 14 alpha demethylase inhibitor
0,222  0,034  Muscular dystrophy treatment
0,203  0,015  Growth stimulant
0,239  0,053  VCAM1 expression inhibitor
0,198  0,014  Antineoplastic, alkylator
0,250  0,068  Antineoplastic (sarcoma)
0,255  0,074  Hypoglycemic
0,182  0,001  Hedgehog signaling activator
0,240  0,060  Antineoplastic enhancer
0,213  0,034  Toxic, respiratory center
0,212  0,035  Interleukin 6 antagonist
0,209  0,032  Antidiarrheal
0,189  0,014  Estrogen antagonist
0,176  0,002  Vitamin D receptor antagonist
0,198  0,036  Bone formation stimulant
0,187  0,029  Glutathione S-transferase substrate
0,160  0,005  CDC25B inhibitor
0,166  0,013  Inducible nitric-oxide synthase inhibitor
0,210  0,058  P-glycoprotein inhibitor
0,155  0,005  Liver X receptor agonist
0,155  0,006  Progesterone antagonist
0,166  0,019  AMP-activated protein kinase stimulant
0,149  0,007  Estrogen receptor beta agonist
0,242  0,101  Cardioprotectant
0,215  0,078  EphB2 antagonist
0,152  0,015  SULT1E1 substrate
0,164  0,028  Antineoplastic antibiotic
0,168  0,034  Antihemorrhagic
0,180  0,050  Lipid peroxidase inhibitor
0,233  0,104  Antidiabetic (type 2)
0,273  0,144  Antiprotozoal
0,141  0,019  Paget's disease treatment
0,131  0,011  Cushing's syndrome treatment
0,134  0,014  Estrogen receptor alpha antagonist
0,125  0,007  Aldosterone antagonist
0,137  0,020  Estrogen receptor beta antagonist
0,144  0,029  Antineoplastic alkaloid
0,157  0,044  Monophenol monooxygenase inhibitor
0,205  0,093  RNA-directed DNA polymerase inhibitor
0,115  0,004  Lipocortins synthesis agonist
0,167  0,059  Antineoplastic (carcinoma)
0,251  0,146  Calcium channel activator
0,108  0,003  Cholesterol absorption inhibitor
0,109  0,005  Postcoital contraceptive
0,134  0,031  Toll-Like receptor 4 antagonist
0,099  0,001  Vitamin D receptor agonist
0,102  0,005  Glucocorticoid antagonist
0,110  0,015  Ca(v)3.1 blocker
0,111  0,017  SULT1A2 substrate
0,096  0,004  Farnesoid X receptor agonist
0,110  0,019  HIV-1 integrase (Strand Transfer) inhibitor
0,094  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,093  0,004  Parathyroid hormone antagonist
0,198  0,109  Antidiabetic symptomatic
0,151  0,063  Skeletal muscle relaxant
0,170  0,083  Diabetic nephropathy treatment
0,196  0,112  Antihypotensive
0,141  0,062  Cyclooxygenase 1 inhibitor
0,186  0,108  Antiviral (HIV)
0,126  0,051  SULT1A1 substrate
0,159  0,086  Male reproductive disfunction treatment
0,166  0,092  Antihelmintic
0,188  0,115  Vasodilator
0,140  0,067  Antieczematic
0,121  0,050  Expectorant
0,096  0,026  Premenstrual syndrome treatment
0,129  0,060  Alkylator
0,119  0,051  Neutropenia treatment
0,141  0,074  Antifungal (Cryptococcus)
0,187  0,121  Vascular (periferal) disease treatment
0,077  0,012  Mineralocorticoid receptor antagonist
0,069  0,004  HMG CoA reductase inhibitor
0,117  0,052  HDL-cholesterol increasing
0,138  0,074  Antineoplastic (squamous cell carcinoma)
0,101  0,038  Transcription factor NF kappa B stimulant
0,144  0,081  Insulin secretagoues
0,159  0,097  Antineoplastic (bone cancer)
0,081  0,018  Andropause treatment
0,126  0,064  Antiviral (Hepatitis B)
0,122  0,064  Proteasome inhibitor
0,201  0,144  Antihypoxic
0,080  0,025  SULT2A1 substrate
0,070  0,015  Anesthetic inhalation
0,061  0,008  Liver X receptor beta agonist
0,056  0,005  CYP24 inhibitor
0,058  0,007  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,058  0,010  Hypogonadism treatment
0,219  0,172  Antiprotozoal (Plasmodium)
0,174  0,127  Antineoplastic (non-small cell lung cancer)
0,108  0,067  Mucolytic
0,143  0,103  Antipruritic
0,044  0,004  Ileal bile acid transport inhibitor
0,158  0,119  CYP2B6 inhibitor
0,139  0,101  Uterine stimulant
0,042  0,004  Corticosteroid-like
0,045  0,008  Estrone sulfatase inhibitor
0,133  0,096  Adenylate cyclase stimulant
0,042  0,005  Glucocorticoid agonist
0,039  0,005  Progesterone agonist
0,055  0,022  Microtubule stabilization
0,108  0,076  Anesthetic local
0,155  0,126  Insulin sensitizer
0,064  0,036  Heme oxygenase stimulant
0,033  0,005  Apical sodium codependent bile acid transporter inhibitor
0,147  0,119  Psychostimulant
0,107  0,081  Menstruation disorders treatment
0,033  0,009  1,3-Beta-glucan synthase inhibitor
0,089  0,067  Protein kinase C zeta inhibitor
0,116  0,098  Vanilloid 1 agonist
0,082  0,065  Ornithine decarboxylase inhibitor
0,036  0,020  Squalene synthetase inhibitor
0,019  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,167  0,152  Age-related macular degeneration treatment
0,104  0,092  Aldehyde dehydrogenase inhibitor
0,036  0,024  Ceramide glucosyltransferase inhibitor
0,052  0,040  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,013  0,002  Transcortin receptor antagonist
0,194  0,185  Antithrombotic
0,059  0,051  Nitric oxide donor
0,083  0,076  Prolactin inhibitor
0,008  0,002  Vitamin D-like
0,072  0,067  Antitreponemal
0,058  0,058  Neuraminidase (influenza) inhibitor
0,062  0,062  Lipase inhibitor

